Assays on progressed/priority compounds.

The primary goal of the consortium (ENABLE) is to create a drug discovery platform with the expertise and resources to prosecute multiple antibacterial programmes in parallel to boost the overall pipeline in the antibacterial area. The profiling specified in this document is included in a screening funnel describe in the following 2 paragraphs: Tier 3 H2L. Assays on progressed/priority compounds. 3.21. In vitro pharmacology profiling. Test at 10 µM against a profiling panel of (c. 30) human enzymes/receptors/transporters/ion channels. For key targets with 50 % inhibition at 10 µM, IC50 will be measured. Tier 7 L2C (Profiling of advanced Lead compounds) 7.7. In vitro pharmacology profiling. Test at 10 µM against a profiling panel (c. 100 human enzymes/receptors/transporters/ion channels). For key targets with 50 % inhibition at 10 µM, IC50 will be measured. For those targets with IC50 below 1 µM, functional effects will be measured.
CPV-Code: 73111000
Abgabefrist: 22.01.2015
Typ: Contract notice
Status: Submission for all lots
Aufgabe: Education
Vergabestelle:
name: e-Avrop
address: Lägerhyddsvägen 2, hus 3
postal_code: 751 08
city: Uppsala - SE
country: SE
email: None
phone: None
contact_point:
idate: 23. Juni 2020 09:42
udate: 23. Juni 2020 09:42
doc: 415363_2014.xml
authority_types: MINISTRY
activities: EDUCATION
Quelle: http://ted.europa.eu/udl?uri=TED:NOTICE:415363-2014:TEXT:EN:HTML
Unterlagen: None
Zuschlagskriterium: Lowest price
Vertrag: Service contract
Prozedur: Open procedure
Nuts: SE121
Veröffentlichung: 06.12.2014
Erfüllungsort: Uppsala - SE
Link:
Lose:
Name Los Nr 1 Sweden__Uppsala__Forschungslabordienste
Gewinner None
Datum
Wert None
Anzahl Angebote None